Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAC-14028 in pediatric atopic dermatitis
NCT02748993Phase 2Completed
- Sponsor
- Amorepacific Corporation
- Start
- Mar 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of asivatrep in atopic dermatitis (AD), sponsored by Amorepacific Corporation. Started Mar 2016; status: completed.
02
Drugs
asivatrep
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02748993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02748993.